Introduction: There are few longitudinal studies of dementia in developing countries. We used longitudinal data from the Maracaibo Aging Study to accurately determine the age-and sex-specific incidence of dementia in elderly Latin Americans. Methods: The Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) was used to diagnose dementia, which was classified as Alzheimer's disease, vascular dementia, or other. Age-and sex-specific incidence was estimated as the number of new cases of dementia divided by person-years (p-y) of follow-up.
Introduction
The prevalence of dementia, a condition that disproportionately affects the elderly, is higher in most Latin American countries than in developed countries [1] [2] [3] . In 2015, approximately 70.9 million Latin Americans were older than 60 years. By 2030, that number will exceed 121 million [4] . As such, the aging of the population puts an increasing number of individuals at risk. However, because prevalence reflects both the incidence and duration of disease, it is a limited measure of risk.
Incidence, the rate of occurrence of new cases, is a more useful measure of risk that is essential for evaluating temporal trends and for assessing the effects of preventative measures. The World Health Organization's estimates of the incidence of dementia in developed countries ranged from 3.4 per 1000 person-years (p-y) at age 60-64 years to 99.4 per 1000 p-y at age greater than 95 years [3] . There are only nine reports on the incidence of dementia in developing countries [5] [6] [7] [8] [9] [10] [11] [12] , all among those older than 65 years, and ranging from 3.2 per 1000 p-y in India [11] to 21 .85 per 1000 p-y in Nigeria [7] . None of these studies included complete neuropsychological and clinical assessments of all participants.
The goal of the present study is to provide an accurate estimate of dementia incidence in Venezuela, a developing country. Longitudinal data from the Maracaibo Aging Study (MAS) [13] were used to determine the age-and sex-specific incidence of dementia and its subtypes, Alzheimer's disease (AD), and vascular dementia (VaD).
Methods

Sample
The MAS is a population-based study of communitydwelling individuals aged 55 years and older who resided in downtown Maracaibo, Santa Lucia County, Venezuela, between January and August 1998 [14] . The MAS investigated cognitive, cardiovascular, nutritional, and social changes associated with aging, with a special emphasis on memory-related disorders. The baseline assessment was conducted between September 1998 and December 2001. A total of 2453 of 3765 residents aged 55 years or older underwent a standardized, multidimensional assessment of laboratory tests and their neuropsychological, neuropsychiatric, cardiovascular, and nutritional status. Of the 2453 assessed at the baseline evaluation, 198 participants were diagnosed as having dementia, and one participant was not assigned a Clinical Dementia Rating (CDR) [15] . Of the remaining 2254 assessed patients who composed the at-risk population, 411 (19.74%) died or relocated before the second evaluation, 28 (1.24%) were not available for any of the three reevaluation visits, and 122 (5.12%) declined to participate in the second evaluation. The 1693 participants who were reexamined at least once between 2001 and 2009 composed the sample for our study (Fig. 1) .
The MAS was approved by the Institutional Review Board of the Cardiovascular Center at the University of Zulia in Maracaibo. Informed consent was obtained from each participant, or from a surrogate when appropriate, after they were provided with a complete explanation of the study.
Dementia assessments and diagnoses
The assessment and diagnostic procedures of the MAS have been previously described in detail [13] . Briefly, a social worker visited the home of each participant and conducted a family interview. Two social workers were available during the study period, both of whom received the same training, which consisted of practice interviews, role-playing, visits to Santa Luc ıa with various members of the team (psychologists, physicians, historian) to understand the geography and history of the area, and biweekly feedback meetings. An informant (usually a spouse or adult child residing in the same home as the participant) was identified as knowledgeable about the participant's daily activities and health issues. Information regarding changes in the abilities of the participant was collected using an adapted version of the Dementia Questionnaire [16] , the third part of the Blessed Dementia Scale [17] , and the Self-Maintaining and Instrumental Activities of Daily Living Scale [18] , as well as information on the family history of dementia. All the participants were invited to undergo an in-depth neuropsychiatric evaluation (performed by a trained neurologist, psychiatrist, or internist), neuropsychological testing (by a psychologist), routine laboratory tests, and apolipoprotein E (APOE) genotyping [19, 20] .
The neuropsychiatric assessment included a neurologic examination, original and modified versions of the Mini-Mental State Examination (MMSE) [21, 22] , the Blessed Orientation-Memory and Concentration Test [17] , the Schwab and England Scale to assess activities of daily living [23] , the Zung Depression Scale [24] , and the Neuropsychiatric Inventory [25] .
The neuropsychological assessment included 17 tests for memory, abstract reasoning, orientation, constructional ability, language, and attention [22] : the Selective Reminding Test [26] ; the Benton Visual Retention Test [27] ; similarities from Wechsler Adult Intelligence Scale-Revised [28] ; identities and oddities from Mattis [29] ; five items from the Rosen Drawing Test [30] ; the Boston Naming Test [31] ; the Benton Multilingual Aphasia Examination [32] ; comprehension and repetition from the Boston Diagnostic Aphasia Examination [31] ; and cancellation (TMX and shapes).
Results of the neuropsychological tests were used as complementary information; diagnoses were not based on cutoff scores. The assessments were conducted on two consecutive mornings, usually at the Cardiovascular Center of the University of Zulia. If the participant could not leave their home, the assessment took place at the their residence.
Diagnoses of dementia were made by consensus during a conference of physicians, psychologists, and social workers, who discussed all ancillary information and followed the diagnostic strategy developed for the Washington HeightsInwood Columbia Aging Project in New York [22] . Subjects were classified as having dementia if they obtained a rating of category 1 or higher on the CDR scale [15] and they had cognitive impairment resulting in a functional decline in their social or occupational activities from their previous level of functioning not explained by other conditions. Baseline and incident dementia diagnoses were classified as AD, VaD, or other dementia based on standardized criteria for each illness in the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) [33] and specific criteria for each dementia subtype [34] [35] [36] [37] [38] [39] [40] . Brain magnetic resonance scans (Phillips 1.5 T) were offered to all individuals with CDR 0.5 or higher and to randomly selected individuals for a total of 400 imaging studies. When available, neuroimages were included in the discussion, and they were mostly used for differential diagnosis. Dementia onset was estimated as the age at which the individual met the criteria for dementia, based on a systematic review of the chronological history of cognitive and functional changes. The consensus panel was blind to APOE genotype, previous CDR, and dementia type.
Data analysis
The at-risk population consisted of MAS participants who were not diagnosed with dementia during the baseline assessment. For each participant, p-y was calculated as the number of years from baseline until (1) the time of dementia onset or (2) the time of completion of the last assessment at which the individual was found not to have dementia, whether they subsequently remained in the cohort, dropped out, or died. Incidence per 1000 p-y was estimated as the number of new cases of dementia, divided by the at-risk py, multiplied by 1000 [41] . Confidence intervals were calculated assuming a Poisson distribution for the number of cases within each age interval. Incidences were standardized using the Venezuelan population based on the 2001 national census [42] and the WHO world population data [43] .
Because factors leading to nonparticipation could be linked to the same factors that affect dementia incidence [44] , we conducted two types of analyses to assess the influence of dropouts (due to death, relocation, refusal, or other cause of nonparticipation) having developed dementia if they have stayed in the study. First, a sensitivity analysis was conducted, which assumed that dementia incidence in nonparticipants was the same, 50%, 100%, or 200% higher than the incidence in the assessed cohort. The second approach consisted of adjustment of incidence for competing risk due to death using a proportional subdistribution hazards model developed by Fine and Gray [45] and modified by Chang et al. [46] . Briefly, a propensity model was developed using a logistic regression model with covariates (age, sex, and education) assigning each individual a propensity score that reflected his/her estimated probability of developing dementia, have all they been assessed for dementia an additional time after baseline. On the basis of the median of the propensity score of those that actually developed dementia a cut point was established. If the propensity score of participants who died without developing dementia were greater than the cut point, they were reclassified as an event and incidence of dementia recalculated.
We fitted three types of regression models to estimate the effect of age, education, sex (female), and APOE 34 genotype on the incidence of dementia (all causes, AD, and VaD). First, Cox proportional hazard regression models [47] , in which participants who survived and remained dementia-free and those who died without developing dementia, were treated as censored. Second, the modified Fine and Gray (FG) competing risks regression models that focus on cumulative incidence [45] were generated using the command stcrreg in STATA (StataCorp. College Station, TX, USA). Third, the FG models were generated after reclassification of individuals, that is, participants who remained alive and dementia-free were again treated as censored, but those who died without developing dementia were treated either as competing risks (if their propensity scores were greater than the cut point) or as censored (if their propensity scores were less than the cut point).
Mean values of population parameters (6standard deviation) were compared using the Mann-Whitney rank sum test, and P values less than .05 were considered to be statistically significant. Statistical analyses were performed with Epi-Info 6.04b (Centers for Disease Control and Prevention, Atlanta, GA, USA) and SPSS version 23.0, 2016 (IBM Corp, Armonk, NY, USA).
Results
The mean age at baseline for study participants with longitudinal data was 66.3 years, and 69.5% of the study participants were women ( Table 1 ). The study participants had, on average, 6 years of education and their mean MMSE was 23.7. The average number of follow-up visits by participants was 2.4 (range 2-5), and the time between the baseline and last assessments averaged 3.45 6 3.05 years ( Table 2 ). The mean age at first diagnosis of incident dementia was 75.1 6 8.11 years. Table 1 provides statistics for individuals who did not participate in any follow-up evaluation due to death, relocation, refusal, or other cause. They were slightly older than those who did participate and included a smaller proportion of women. The nonparticipant group did not differ from participants with respect to years of education, APOE 34 genotype, or mean MMSE score obtained during the baseline evaluation.
Incidence of all dementia diagnoses was nine cases per 1000 p-y for participants aged 55 years or older and 16 cases per 1000 p-y for participants aged 65 years or older. The incidence of dementia increased exponentially with age, reaching 91 cases per 1000 p-y for individuals aged 85 years or older (Table 3, Fig. 2 ). The incidence of AD and VaD also increased with age (Table 3) . AD accounted for 56% and VaD for 36% of all incident dementia cases with marginal cases of frontotemporal dementia, Lewy body disease, Parkinson's with dementia, and dementia related to alcoholism. The incidence of all dementias, AD, and VaD was similar for men and women. The incidence of all dementias and AD was higher among APOE 34 carriers than noncarriers, but the presence of an APOE 34 allele did not affect the incidence of VaD (Table 4 ).
In the sensitivity analyses, the age-specific incidence of dementia was recalculated to include nonparticipants, assuming that the nonparticipants had 1.5 to 5 times greater incidence of dementia than participants (Supplementary Table 1 ). As expected, the recalculated incidence was higher, particularly in the older groups, than when nonparticipants and participants were assumed to have the same incidence of dementia. When incidence was calculated using the modified FG competing risks regression models, incidence was substantially higher than the unadjusted models (Supplementary Table 1) , particularly in the older groups.
Results of the Cox models indicated that being older, female, or a carrier of at least one APOE 34 allele was associated with an increased incidence of dementia of all causes (Supplementary Table 2 ). However, only age and APOE 34 status were significant risk factors for AD, and only age was a risk factor for VaD. In unadjusted models, low education level was not a significant risk factor for all-cause dementias, AD, or VaD. After adjusting for death as competing risk, results were not radically changed, except for education, which became marginally significant for all-cause dementia and VaD but not for AD and sex, which became significant for the three dementia groups. NOTE. P indicates the difference between subjects by dementia status. (18); SD, standard deviation. NOTE. P indicates the significance of the difference between subjects with only the baseline assessment and those with 1 follow-up assessment.
Discussion
The MAS previously reported a high prevalence of dementia in the elderly population of Santa Lucia compared with other population-based studies in Latin America [2] . However, it was uncertain whether the high prevalence reflected a high incidence of dementia. We conducted an extensive follow-up evaluation of each participant by experienced local clinicians, using standardized full neuropsychological testing, neurologic examination, and a multimodal examination of decline in activities of daily living. The results of the present longitudinal study confirm that age at onset of dementia is somewhat earlier than in US Whites [49] as evident by the relatively high incidence of dementia among MAS participants who are younger than 65 years. However, the incidence of dementia in those older than 65 years was comparable to other population-based data from other studies [5] [6] [7] [8] [9] [10] 12] . When adjusting for death as a competing risk for dementia, using a relative conservative approach, the resulting incidence per age group have not precedents. This finding suggests that dementia and death shared common risk factors, and once the development of public health sector and of medical science allows decreasing mortality rates, the magnitude of dementia rates could be much higher.
Consistent with the prevalence data, AD was the most frequent type of incident dementia. As expected, age, sex, and APOE 34 were important risk factors for dementia. The average years of education were 6 years, which is consistent with the average years of schooling of adults in the Venezuela [50] for that age range, and was associated with dementia only when competing risks were considered. The mild significant association with education level could be because of the overall low level of education of the cohort.
The present study has several limitations. The primary limitation is that incidence rates were derived from a geographically restricted area and are not necessarily representative of all Venezuelans or Latin Americans. Moreover, our dementia diagnoses rely on extensive clinical evaluation but have not been autopsy confirmed by neuropathologic evaluation. Thus, we may have underestimated subtypes of Abbreviations: CI, confidence interval; p-y, person-years. *Age-standardized incidence based on the age structure of the Venezuelan population [42] .
y Age-standardized incidence based on the age structure of the world population [43] . Fig. 2 . Incidence of dementia versus mean age reported herein for the Maracaibo Aging Study (MAS, Venezuela) and for comparison purposes, in six previous studies: Brazil 5 Catanduva, Brazil Study [9] ; China 5 Anhui Cohort Study [6] ; EURODEM 5 European Studies of Dementia (Denmark, France, Netherlands, United Kingdom) [48] ; Latin America 10/66 (Dominican Republic, Peru, Venezuela) [10] ; Mexico 5 Mexican Health and Aging Study [8] ; and Rochester 5 Rochester, MN, Study (USA) [49] . dementia, such as VaD and others. Unlike other communitybased studies of dementia in developing countries, however, we were able to verify VaD using neuroimaging data because 67% of cases of dementia had neuroimaging. The high incidence of dementia might reflect anticipation of onset, more severe manifestation during early stages, or highly sensitive diagnoses. None of these possibilities can be excluded in the present study. The Santa Lucia population lives in poor conditions relative to other populations in developed countries, including limited access to health care, which leads to high rates of uncontrolled comorbidities such as systemic hypertension and diabetes. When compared with incidence rates among Caribbean Hispanics residing in northern Manhattan, the incidence of AD in the Santa Lucia cohort was higher (3.8% vs. 6.9% per 1000 p-y, respectively). Because both studies used similar diagnostic procedures and analytical methods, the possibility that there is a risk factor for AD specific to the MAS population cannot be ruled out [51] . However, most of the Caribbean Hispanics in the US study were from the Dominican Republic and Puerto Rico; few were from Venezuela. Finally, results of the sensitivity analysis indicate that the estimated incidence would have been higher if dementia-related incapacity, relocation, or death accounted for a significant proportion of nonparticipants, and modeling death as a competing risk of dementia revealed that the overall dementia rate could be twice as the unadjusted.
On the other hand, the present study has many strengths. This community-based study is as representative as possible of the population in the region, because all residents 55 years or older were invited to participate and the participation rate at baseline was higher than 75% [13] . The nonparticipation rate in follow-ups, excluding death and relocation, was approximately 5%; thus, the probability that self-selection influenced the estimates of incidence is low. We used validated questionnaires and detailed neuropsychological instruments that provided extensive, in-depth clinical phenotyping. The diagnostic strategy and most of the health professionals involved in assessments were the same for the baseline and follow-up studies, thus minimizing assessment bias. The health professionals involved in the MAS diagnostic process included a psychiatrist, a geriatrician, and usually also a neurologist, all with specific training, expertise, and experience in dementia. Although "diagnostic drift" (the tendency to expand the parameters of a diagnosis leading to more diagnoses) cannot be excluded, cognitive performance cutoffs were established giving careful consideration to education level to minimize the possibility that the tests penalized individuals with lower education level and to ensure that the same diagnostic criteria were applied. The noted association between the APOE 34 genotype and the incidence of AD, but not VaD, further validates our results.
The present study provides the first estimates of the incidence of dementia, AD, and VaD for a population in the developing world that was not subject to a screening phase before assessment and in which diagnoses were not paradigm-based but the result of clinical consensus. The incidence of dementia, AD, and VaD in participants older than 65 years reported herein are comparable to the range of estimates previously reported for both developed [44, 48, 52] and developing [8] [9] [10] 12 ] countries (Fig. 2) . The incidence among those aged 55-64 years is quite high compared with studies in the developed world [49] , and there is only one other reported study in the developing world for this age group, which took place in India and which also found lower rates than MAS [5] . However, direct comparisons to previous estimates of dementia incidence are difficult because of differences in the diagnostic methods, the age structure of the samples, and the use of different age strata in the analyses. We did not preselect individuals to be evaluated in depth by expert clinicians to undergo extensive neuropsychological assessment or for all participants to undergo laboratory tests. Previous incidence studies of dementia in the developing world have carefully validated their methods, diagnostic strategies. We are building on their insight of the difficulties of carrying out these studies in low-resource settings, not only presenting data of Venezuela but also adding some methodological features. All previous incidence studies in the developing world [5] [6] [7] [8] [9] [10] [11] [12] applied a screening phase to select those individuals who were more likely to be diagnosed as having dementia. Some used laboratory tests to evaluate physical health [5, 9, 11] , three obtained information on daily living activities from the participant and a proxy [7] [8] [9] [10] , and two included magnetic resonance imaging of the brain [5, 11] . Only other study reported using a consensus conference of multidisciplinary health professionals to reach a diagnosis for all participants [9] .
The incidence rates reported herein would have been even higher if participants with a CDR of 0.5 were counted as having dementia and if competing risk analyses account for those individuals that die before a diagnosis of dementia is actually recorded in the study. Thus, methodology can have a significant effect on estimates of incidence, and the wide range of incidence estimates in previous studies might reflect differences in methodology as much as actual differences in the incidence of dementia. In summary, an accurate estimated incidence of dementia in the population of Maracaibo, Venezuela, showed fairly high rates in those younger than 65 years and rates comparable to previous estimates in those older than 65 years for other countries. The wide range among previous estimates might be at least partly attributable to variation in methodology. Although the incidence of dementia was highest among the most elderly MAS participants, the impact is more important for relatively young individuals (55-64 years) who contribute to the economic support of their families, which are typically multigenerational and poor. Although AD had the highest incidence of the subtypes of dementia, VaD also had a relatively high incidence. Unlike AD, VaD currently offers significant opportunities for prevention. Although extrapolation to other Latin American countries or to Hispanic populations living in developed countries is not straightforward, the relatively high incidence of dementia reported here is of concern, especially given life expectancy in these developing countries has been increasing significantly. The burden on the health care system is likely to be notable when health care resources are limited.
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RESEARCH IN CONTEXT
1. Systematic review: We reviewed the literature using PubMed and reference lists from relevant articles. Studies of incidence of dementia in developing countries and, in particular, in Latin America are scarce. We identified several publications on subjects older than 65 years but none among younger than 65 and residing in a Latin American country.
2. Interpretation: Studies have shown that overall prevalence of dementia in Latin Americas as high as in developed countries. We extend research of epidemiology of dementia by including a population-based incidence study and including individuals 55 years or older. We found that compared with Whites in the United States, this Latin American population has high incidence in the age group 55 to 64 years and intermediate incidence in older than 65 years.
